Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Highlights Diagnostic Technologies for Point-of-Care Testing Applications

By LabMedica International staff writers
Posted on 13 Nov 2023

EKF Diagnostics (Cardiff, Wales, UK) is showcasing its diagnostic technologies and biotechnology solutions at MEDICA 2023 that empower healthcare and medical providers to make informed clinical decisions through point-of-care testing and life sciences applications. More...

EKF offers cutting-edge point-of-care diagnostic solutions that provide healthcare professionals and patients with rapid, accurate, and accessible testing capabilities and results. The company’s technologies allow for informed decision-making, timely interventions, and improved patient outcomes at the point of care. EKF leads in supporting life sciences applications and research through innovative biotechnology solutions. The company’s comprehensive portfolio offers powerful tools to researchers, scientists, and clinicians for accurate and reliable delivery and results, driving breakthrough discoveries and advancements in healthcare and medical understanding.

Visitors to the EKF booth can explore the company’s range of point-of-care medical diagnostic solutions for hematology and diabetes, including the DiaSpect Tm and Hemo Control hemoglobin analyzers, the Biosen C-Line glucose and lactate analyzer, and the Quo-Test and Quo-Lab HbA1c Analyzers. They can also discover more about EKF Link, the company’s optional software platform designed to provide a flexible and secure method for connecting point-of-care devices to hospital and laboratory IT systems. Additionally, visitors can learn more about EKF Life Sciences, and the company’s latest developments in microbial fermentation, custom bioprocessing, and contract manufacturing.

EKF’s DiaSpect Tm is a hand-held analyzer that provides immediate hemoglobin results and hematocrit calculation while the Hemo Control hemoglobin analyzer delivers accurate hemoglobin and hematocrit results with one simple test. Similarly, the Biosen C-Line Line glucose and lactate analyzer from EKF is designed for lab-accurate glucose and lactate measurement in one test. Among other products on display at MEDICA 2023 is the revolutionary Quo-Lab semi-automated analyzer for HbA1c measurement that provides affordable A1c testing with results in just four minutes. The Quo-Test fully automated analyzer on display at MEDICA 2023 is designed for fast, accurate, and reliable HbA1c measurement with results available in only four minutes.

Related Links:
EKF Diagnostics 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.